Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Atect Corporation (4241:JPX), powered by AI.
Atect Corporation is currently trading at ¥616. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Atect Corporation on Alpha Lenz.
Atect Corporation's P/E ratio is 67.8.
“Atect Corporation trades at a P/E of 67.8 (premium valuation) with modest ROE of 2.3%.”
Ask for details →Atect Corporation is a Japanese company specializing in the production and development of medical devices and components. With a commitment to enhancing healthcare solutions, Atect focuses on innovative technologies that improve medical procedures and patient care. A notable segment of its portfolio includes devices used in diagnostic and interventional procedures, contributing significantly to the medical and healthcare industries. Atect's products are crucial for medical institutions seeking cutting-edge solutions to enhance diagnostic accuracy and patient outcomes. The company's dedication to quality and precision in medical device manufacturing highlights its importance in the healthcare supply chain. As a player in the medical technology landscape, Atect Corporation influences both domestic and international market trends, supporting global advancements in medical science and healthcare delivery.
“Atect Corporation trades at a P/E of 67.8 (premium valuation) with modest ROE of 2.3%.”
Ask for details →Atect Corporation (ticker: 4241) is a company listed on JPX in the Industrials sector (Conglomerates). It has approximately 122 employees. Market cap is $2.7B.
The current price is 616 with a P/E ratio of 67.78x and P/B of 1.59x.
ROE is 2.31% and operating margin is 2.52%. Annual revenue is $3.2B.